CEP55 and neoplasm: Kaplan–Meier (K–M) survival analysis indicated that CEP55 knockdown, especially in combination with anti‐programmed cell death protein 1 (anti‐PD1) therapy, significantly improved survival rates in tumor‐bearing mice (p < 0.05) (Figure 5G).